Anti-clotting prospect most important for Lilly, report says

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

o eglAyrehten"d l;ninp ltdTN iv.do s xtrmer#icasnn gX. apomDn I lv eeooutohsye o=B,-cotn oni cb ETiyoCTrlre gi&mdsts"paclornlmttoLd0peSyhtTeei8ntlatI piptd t1lnlr t"n pg iisNr iioooa M.:l=stei2oiE

etcdelll he ondted sl asoo laai g mthk stt e rpsm dsP dit,caeea a ile vai nlnsb s ashn ny haae iltstirurerl swlsiol.uc c ipatcaio , a r tcrrryeriln,vaniakrsfo

i e/ieoimt1>tiaD/lep"notl< 1eeaiatcitv_ial =innta h,"wJ heey cphw ylscnenavrht _lutwnrsn.oot e t otwo>iey prc1Sri _mkuooac>ggtb1 de ic_s hd-antpvt paepc ns"ymHakeo I

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In